subject area of
- AMPK as a Therapeutic Target for Treating Metabolic Diseases Academic Article
- Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models Academic Article
- Adverse metabolic effects of a hypercaloric, high-fat diet in rodents precede observable changes in body weight Academic Article
- Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys Academic Article
- Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats Academic Article
- Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials Academic Article
- Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation Academic Article
- Fructose, pregnancy and later life impacts Academic Article
- Fructose-Containing Sugars, Blood Pressure, and Cardiometabolic Risk: A Critical Review Academic Article
- Increased incidence of non-alcoholic fatty liver disease in male rat offspring exposed to fluoxetine during fetal and neonatal life involves the NLRP3 inflammasome and augmented de novo hepatic lipogenesis Academic Article
- Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis Academic Article
- Maternal taurine supplementation attenuates maternal fructose-induced metabolic and inflammatory dysregulation and partially reverses adverse metabolic programming in offspring Academic Article
- Offspring of Mothers Fed a High Fat Diet Display Hepatic Cell Cycle Inhibition and Associated Changes in Gene Expression and DNA Methylation Academic Article
- Overstated Associations Between Fructose and Nonalcoholic Fatty Liver Disease Academic Article
- Treatment of nonalcoholic fatty liver disease: role of AMPK Academic Article
- Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease Academic Article